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Objectives: To elucidate cell free DNA (cfDNA) clearance kinetics following an acute bout of high intensity
exercise by measuring circulating DNase activity reduction (AR).
Design and methods: Serum cfDNA concentration and DNase-AR were measured prior to and post
(immediately post, 7 and 30 min post) an acute bout of rowing exercise until exhaustion.
Results: Serum cfDNA concentration was signiﬁcantly (P ≤ .001) elevated immediately post (2.5-fold)
and 7 min post exercise (2.3-fold) with a return close to baseline at 30 min post exercise (1.5-fold). The rise in
cfDNA was accompanied by a concomitant, signiﬁcant (P ≤ .001) decrease in serum DNase-AR from 15.1%
prior to exercise to 3.1%AR at cessation of the exercise test and 7 min post exercise (3.9% AR). DNase-AR returned
close to baseline at 30 min post exercise (5.2% AR).
Conclusions: A single bout of high intensity exercise is a potent stimulus for enhancing circulating DNase ac-
tivity in healthy people. Acute exercisemay therefore be considered as a non-pharmacological stimulus to trigger
DNase activity.
Thisﬁndingmay be relevant for pathological conditions associatedwith increased cfDNA concentrations like cys-
tic ﬁbrosis, where pharmacological recombinant human DNase (rhDNase) treatment has been successfully used
to improve patients' health and physical function.
© 2013 The Authors. The Canadian Society of Clinical Chemists. Published by Elsevier Inc.
Open access under CC BY-NC-ND license.Introduction
DNase activity in tissues and body ﬂuids clears the system from
endogenous DNA of apoptotic and necrotic cells along with foreign
DNA which originates from food digestion and potential pathogens.
Circulating cell free DNA (cfDNA) in blood is hydrolyzed by DNase and
cleared predominantly via the liver and to a lesser extent (b2%) by the
kidney [1]. DNase activity varies between body ﬂuids, with twice the
activity levels observed in human serum compared to saliva [2].
In healthy conditions cfDNA concentrations have been shown to
increase transiently for minutes in response to acute exercise [3,4] or
prolonged for 96 h in response to long-lasting high resistance exercise
associated with sustained inﬂammation [5].
In pathological conditions like sepsis, cancer, autoimmune diseases,
trauma, myocardial infarction, and pregnancy-associated complications
[6] cfDNA concentrations are elevated aswell. Extracellular DNA in lung
secretions of cystic ﬁbrosis (CF) patients, released from disintegratedRehabilitation Medicine, Ulm
, Germany. Fax: +49 731 500
Schumann).
Clinical Chemists. Published by Elsevimmune cells and bacterial DNA, contributes to the increased viscosity
and reduced effectiveness of antibiotic treatment [7]. CF sputum viscos-
ity is greatly reduced when lung secretions are incubated with rhDNase
in-vitro [7], suggesting that endogenous cfDNA clearance and degrada-
tion mechanisms are impaired or inadequate to cope with pathological
cfDNA levels. This claim is supported by ﬁndings showing that DNase
activity is reduced in several diseases such as cancer, which are associ-
ated with increased levels of cfDNA [8]. Consequently rhDNase was
approved for medication two decades ago and is still one of the most
widely used drugs for treating CF [9].
Since intense exercise induces transient increases in plasma and
serum cfDNA [3,4,10,11], we hypothesized that exercise stimulates cir-
culating DNase activity concomitant to the rise in cfDNA. Here we show
that the reagibility of DNase activity is induced by an acute bout of high
intensity ergometer rowing.
Methods
Study participants and exercise test
Ten highly trained male rowers, all qualiﬁed for the German 2013
Junior National team (Table 1) performed a step-wise incremental exer-
cise trial until exhaustion on a rowing ergometer (Concept 2 Type D,
Morrisville). The exercise test started at 200 W, and the increments
amounted to 50 W/4 min. During a break of 30 s between each stage
and immediately after the last stage, 20 μl of capillary blood was takenier Inc. Open access under CC BY-NC-ND license.
Table. 1
Anthropometric data of study participants, maximal (max) power output (P), max blood lactate (La) concentrations, heart rate (HR), total exercise duration, P and La at the individual
anaerobic threshold (IAT), and fold-increase of max P and La versus IAT measured after cessation of the incremental rowing test to exhaustion.
Age
[years]
Height
[cm]
Body mass
[kg]
BMI
[kg/m2]
P max
[W]
La max
[mmol/l]
HR max
[min−1]
Total duration
[s]
P IAT
[W]
La IAT
[mmol/l]
P max/
P IAT
La max/
La IAT
Mean 17 190 85.3 23.5 422.4 13.8 202 1260 300 2.9 1.41 4.76
SD 0.5 4 5.1 1.6 29.9 3.4 7 125 14 0.4 0.08 0.91
CV [%] 2.9 2.1 6 6.8 7.1 24.7 3.4 9.9 4.6 15.1 5.6 19.2
Min 17 182 77.3 21 374.9 9.1 193 1053 283 2.2 1.3 3.67
Max 18 197 91.1 26 468.7 20.4 217 1477 320 3.6 1.54 6.83
472 M. Velders et al. / Clinical Biochemistry 47 (2014) 471–474from the hyperemized ear lobe and analyzed for blood lactate (Biosen
S-Line, EKF; Barsleben, Germany). Prior to and post (immediately post,
7 and 30 min post) exercise larger volume capillary blood samples
(300 μl) were drawn from the ear lobe using a Microvette CB 300
(Sarstedt, Germany). All participants were asked to keep physical ac-
tivity at a minimum until the last blood collection. Blood samples
were allowed to clot for 15 min followed by centrifugation at 10,000 g
for 10 min at room temperature. Serum was stored at−80 °C for sub-
sequent analysis. Time points were chosen based on studies showing
that cfDNA levels return to baseline between 30 min and 1 h post exer-
cise [4,11].
The Human Ethics Committee of Ulm University approved the ex-
perimental protocol and each individual gave written informed consent
to the study.
cfDNA concentration assay
The cfDNA concentrations were directly analyzed with a ﬂuores-
cent nuclear stain (SYBRGold) in serum samples without prior DNA ex-
traction and ampliﬁcation [13]. Brieﬂy, 40 μl of SYBR Gold (1:10,000
dilution in PBS) was added to 10 μl of serum in 96-well plates. Fluores-
cence was recorded using a spectroﬂuorometer (SAFAS monaco ﬂx
Xenius, Monaco) with an excitation wavelength of 485 nm, and emis-
sion wavelength of 535 nm. A standard curve was generated by serial
dilution of commercial salmon sperm DNA (Sigma-Aldrich).
This SybrGold assaywas shown to exhibit a high correlationwith the
conventional quantitative polymerase chain reaction assay of beta-
globin (R2 = 0.9987, P b .001) [13].
As a control for speciﬁcity of ﬂuorescence signals concurrent
pretreatment of serum samples with recombinant DNase I resulted in
complete extinction of detectable cfDNA.
DNase assay
DNase activity was measured using a commercial solid phase en-
zyme immunoassay (ELISA) ORG590 (ORGENTEC Diagnostica, Mainz,
Germany) according to the manufacturer's protocol. Test principle in
brief: serum DNase reacts with immobilized DNase substrate which re-
sults in a color change. The color intensity is measured photometrically
on amicroplate photometer (Thermo ScientiﬁcMultiscan FC, Fisher Sci-
entiﬁc, Germany) at 450 nm with a correction wavelength of 620 nm.
Statistics
Measurements of cfDNA and DNase-AR were performed in dupli-
cate. Data is expressed as means and SD. The coefﬁcient of determina-
tion (R2) for linearity of cfDNA standard curve was ≥0.97. GraphPad
Prism 5 (La Jolla, CA, USA)was used for statistical analysis and graphical
presentation. D'Agostino & Pearson omnibus K2 test was used to
check for normal distribution, Friedman's test and Dunn's Multiple
Comparison Test to assess matching among groups. Differences of
P b .05 were considered statistically signiﬁcant. For the DNase activity
assay a 4-Parameter-Fit with lin–log coordinates for optical density
and concentration was employed.Results
All athletes performed the exercise trial until exhaustion and
ﬁnished with mean lactate concentrations of 13.8 mmol/l and a mean
power max 422.4 W (Table 1). Exercise intensity was high in all
athletes, because maximal values of blood lactate and power at end of
the experiment were 4.8-fold and 1.4-fold higher compared to values
observed at the individual anaerobic thresholds [12]. Mean heart rate
at test cessation was 202 beats/min with a mean exercise duration of
21 min. Instructions to keep physical activity at a minimum until the
last blood collectionwere obeyed by all participantswith one exception.
The kinetics of cfDNA is shown in Fig. 1A with a highly signiﬁcant
2.5-fold increase from 117 ng/ml cfDNA prior to exercise to an average
of 290 ng/ml at exhaustion. After termination of exercise, excessive
cfDNA is gradually removed from the circulation, declining to 2.3-fold
above resting levels after 7 min and reaching near baseline levels at
30 min post exercise. While all athletes showed the same basic kinetics
in response to acute exercise, individual levels differed with regard to
min/max values and fold changes (Fig. 1D). Noteworthy, 7 min after
cessation of exercise, 5 athletes showed diminished and 5 athletes
increased amounts of cfDNA compared to immediately post exercise.
Another 23 min later 9 of 10 athletes had levels close to baseline with
only one rower showing increased levels compared to post +7 min
(Fig. 1D; dotted line). Apart from the possibility of ameasurement inac-
curacy this athlete's deviant kineticsmight be causedby a noncompliant
cool down behavior. Interestingly, the cfDNA-elevationwas also accom-
panied by prolonged increase in DNase activity indicating the validity of
data acquisition.
DNase activity reduction (AR) was inversely proportional to the
kinetics of cfDNA as revealed in Fig. 1B. DNase AR was signiﬁcantly
reduced (P b .001) from baseline to post exercise 0 min (4.9-fold) and
7 min (3.9-fold) with a trend to return to baseline at 30 min (2.9-fold),
albeit with some delay compared to the kinetics of cfDNA (Fig. 1C).
The latter was reduced to one third of its peak value after 30 min,
while DNase-AR was still about half of its maximum value after 30 min
(Fig. 1C).
Discussion
Exercise of sufﬁcient intensity has been consistently shown to in-
duce rapid, transient increases in circulating cfDNA similar to concen-
trations observed after trauma or sepsis [3,4,10]. Our ﬂuorescent assay
for detection of cfDNA conﬁrmed data acquired by PCR methods [13]
and served previously as a prognostic tool of death and disease in colo-
rectal cancer patients that was even superior to pathologic staging [14].
While the precise origin, triggers and regulation patterns of cfDNA
in athletes exercising at high intensities are still a topic of debate and
subject of ongoing research, we show for the ﬁrst time that signiﬁcantly
elevated levels of cfDNA in healthy trained subjects are efﬁciently
reduced by adaptations of endogenously expressed DNase activity to
regain homeostasis.
Although the precise mechanism underlying the exercise induced
DNase activity alterations remains to be investigated, our ﬁndings
raise the question if exercise serves as a stimulus to evoke enhanced
cf
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Fig. 1.Kinetic time course of cfDNA (A) andDNase activity reduction (B). (C) shows the relationship between cfDNA concentration and DNase-AR during the exercise test. Individual time
courses of cfDNA are presented in (D) with one athlete showing differing kinetics at 30 min post exercise (dotted line). Signiﬁcance levels are as follows, *P b .05, ***P b .0001.
473M. Velders et al. / Clinical Biochemistry 47 (2014) 471–474DNase activity also in patients taking rhDNase as a medication. The
enzymatic processing of sticky cfDNA into shorter chains by DNase re-
duces the viscosity in sputum of CF patients [15] and clinical studies
with CF patients have repeatedly proven that regular inhaling of
rhDNase improves lung function and thereby ameliorates the disease
progress. Considering that chronic inﬂammation in CF patients is not
comparable to the acute and transient inﬂammation in healthy elite
athletes in response to an acute bout of intense exercise, we performed
a similar experiment to exhaustion with male and female recreational
athletes to approximate our ﬁndings to the average population before
premature transfer of results to patients. Kinetics of cfDNA and DNAse
activity resembled those of trained athletes in this study (own unpub-
lished results).
Despite differences between healthy and diseased individuals, tem-
poral alterations and severity of etiopathology, it is common consent
that the general health beneﬁts of exercise activities also apply to CF
patients. This comprises also high intensity exercise programs around
the anaerobic thresholds given that patients' lung function is sufﬁcient
and medical guidance is provided [16].
While our study and data from another exercise study suggests that
the exercise induced kinetics of cfDNA correlates with the production
and release of lactate [4], further studies are required to test whether
exercise protocols consisting of lower intensities and durations, which
may not lead to a signiﬁcant rise in systemic cfDNA concentrations,
are also able to stimulate circulating DNase activity in healthy and
diseased people.Acknowledgment
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